Fresenius Medical Care AG (FMS)
22.16
+0.18
(+0.82%)
USD |
NYSE |
Nov 22, 16:00
22.17
+0.01
(+0.05%)
After-Hours: 20:00
Fresenius Medical Care Enterprise Value: 11.47B for Nov. 22, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 22, 2024 | 11.47B |
| November 21, 2024 | 11.37B |
| November 20, 2024 | 11.26B |
| November 19, 2024 | 11.44B |
| November 18, 2024 | 11.45B |
| November 15, 2024 | 11.48B |
| November 14, 2024 | 10.98B |
| November 13, 2024 | 10.83B |
| November 12, 2024 | 10.92B |
| November 11, 2024 | 11.02B |
| November 08, 2024 | 10.97B |
| November 07, 2024 | 10.99B |
| November 06, 2024 | 10.84B |
| November 05, 2024 | 10.40B |
| November 04, 2024 | 10.23B |
| November 01, 2024 | 10.06B |
| October 31, 2024 | 9.935B |
| October 30, 2024 | 9.683B |
| October 29, 2024 | 10.43B |
| October 28, 2024 | 10.71B |
| October 25, 2024 | 10.75B |
| October 24, 2024 | 11.01B |
| October 23, 2024 | 10.82B |
| October 22, 2024 | 10.73B |
| October 21, 2024 | 10.80B |
| Date | Value |
|---|---|
| October 18, 2024 | 10.50B |
| October 17, 2024 | 10.23B |
| October 16, 2024 | 10.22B |
| October 15, 2024 | 10.21B |
| October 14, 2024 | 10.18B |
| October 11, 2024 | 9.971B |
| October 10, 2024 | 10.13B |
| October 09, 2024 | 10.25B |
| October 08, 2024 | 10.21B |
| October 07, 2024 | 10.55B |
| October 04, 2024 | 10.62B |
| October 03, 2024 | 10.65B |
| October 02, 2024 | 10.87B |
| October 01, 2024 | 10.94B |
| September 30, 2024 | 10.97B |
| September 27, 2024 | 19.54B |
| September 26, 2024 | 19.45B |
| September 25, 2024 | 19.37B |
| September 24, 2024 | 19.26B |
| September 23, 2024 | 18.93B |
| September 20, 2024 | 18.92B |
| September 19, 2024 | 19.20B |
| September 18, 2024 | 19.26B |
| September 17, 2024 | 19.29B |
| September 16, 2024 | 19.32B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
9.683B
Minimum
Oct 30 2024
39.02B
Maximum
Jul 29 2020
26.13B
Average
26.83B
Median
Jun 07 2022
Enterprise Value Benchmarks
| BioNTech SE | 8.731B |
| Affimed NV | 24.10M |
| InflaRx NV | 57.82M |
| Immatics NV | 374.70M |
| CureVac NV | -23.05M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 234.26M |
| Revenue (Quarterly) | 5.235B |
| Total Expenses (Quarterly) | 4.771B |
| EPS Diluted (Quarterly) | 0.4014 |
| Gross Profit Margin (Quarterly) | 24.08% |
| Profit Margin (Quarterly) | 4.47% |
| Earnings Yield | 5.51% |
| Operating Earnings Yield | 15.07% |
| Normalized Earnings Yield | 6.414 |